Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
98 hedge funds and large institutions have $385M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 12 closing their positions.
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
33% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 27
5% more funds holding
Funds holding: 93 → 98 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
34% less capital invested
Capital invested by funds: $587M → $385M (-$202M)
89% less call options, than puts
Call options by funds: $95K | Put options by funds: $843K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$17.7M |
| 2 |
AC
Armistice Capital
New York
|
+$14.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$10.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.73M |
| 5 |
Morgan Stanley
New York
|
+$3.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$25M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$22.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.41M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.08M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.12M |
FMTX Hedge Fund Activity: Q1 2022 in Review
98 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q1 2022, worth a combined $385M — down 34% from $587M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new FMTX positions and 12 closed out — a net gain of 5 holders — while 36 added to existing stakes and 27 trimmed.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $17.7M. The largest seller was Fidelity Investments, cutting an estimated $25M.
- 98 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q1 2022, up from 93 in Q4 2021.
- Funds reported $385M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q1 2022, down 34% quarter-over-quarter.
- 17 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q1 2022 and 12 closed out, a net change of +5 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q1 2022 was Deep Track Capital, an estimated $17.7M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q1 2022 was Fidelity Investments, an estimated $25M sold.
Based on aggregated 13F filings for Q1 2022.